Trait anxiety, trait fear and emotionality: The perspective from non-human studies

Personality and Individual Differences

Volumn 50, Issue 7, 2011, Pages 898-906

  McNaughton, N ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Anxiety; Emotionality; Fear; Human; Neuroticism; Rat; Trait

Indexed keywords

EID: 79952619406     PISSN: 01918869     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paid.2010.07.011     Document Type: Article

References (54)

1. Abel E.L., Altman H.J., Commissaris R.L. Maudsley reactive and nonreactive rats in the forced swim test: comparison in fresh water and soiled water. Physiology and Behavior 1992, 52:1117-1119.
2. American Psychiatric Association (1987). DSM-III: Diagnostic and statistical manual of mental disorders (3rd ed. - Revised).
3. American Psychiatric Association (1994). DSM-IV: Diagnostic and statistical manual of mental disorders (4th ed.).
4. Blanchard D.C., Hynd A.L., Minke K.A., Minemoto T., Blanchard R.J. Human defensive behaviors to threat scenarios show parallels to fear- and anxiety-related defense patterns of non-human mammals. Neuroscience and Biobehavioral Reviews 2001, 25:761-770.
5. Blanchard R.J., Blanchard D.C. An ethoexperimental analysis of defense, fear and anxiety. Anxiety 1990, 124-133. Otago University Press, Dunedin. N. McNaughton, G. Andrews (Eds.).
6. Blanchard R.J., Griebel G., Henrie J.A., Blanchard D.C. Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries. Neuroscience and Biobehavioral Reviews 1997, 21:783-789.
7. Blizard D.A. The Maudsley reactive and nonreactive strains: A North American perspective. Behavior Genetics 1981, 11:469-489.
8. Blizard D.A., Adams N. The Maudsley reactive and nonreactive strains: A new perspective. Behavior Genetics 2002, 32:277-299.
9. Broadhurst P.L. Emotionality and the Yerkes-Dodson law. Journal of Experimental Psychology 1957, 54:345-351.
10. Broadhurst P.L. Applications of biometrical genetics to the inheritance of behaviour. Psychogenetics and psychopharmacology 1960, Vol. 1:1-102. Routledge Kegan Paul, London.
11. Broadhurst P.L. The Maudsley reactive and nonreactive strains of rats: A survey. Behavior Genetics 1975, 5:299-319.
12. Carver C.S., Johnson S.L., Joormann J. Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: What depression has in common with impulsive aggression. Psychological Bulletin 2008, 134:912-943.
13. Commissaris R.L., Franklin L., Verbanac J.S., Altman H.J. Maudsley reactive (MR/Har) and non-reactive (MNRA/Har) rats: Performance in an operant conflict paradigm. Physiology and Behavior 1992, 52:873-878.
14. Commissaris R.L., Verbanac J.S., Markovska V.L., Altman H.J., Hill T.J. Anxiety-like and depression-like behavior in Maudsley reactive (MR) and non-reactive (MNRA) rats. Progress in Neuropsychopharmacology and Biological Psychiatry 1996, 20:491-501.
15. Davitz J.R. A historical look at the concepts of fear and defense, and some comments on psychobiology. The language of emotion 1969, Academic Press, New York. P.F. Brain (Ed.).
16. Deakin J.F.W., Graeff F.G. 5-HT and mechanisms of defence. Journal of Psychopharmacology 1991, 5:305-315.
17. Du L., Bakish D., Hrdina P.D. Tryptophan hydroxylase gene 218A/C polymorphism is associated with somatic anxiety in major depressive disorder. Journal of Affective Disorders 2001, 65:37-44.
18. Ekman P. Emotion in the human face 1982, Cambridge University Press, Cambridge.
19. Evans J., Battersby S., Ogilvie A.D., Smith C.A.D., Harmar A.J., Nutt D.J., et al. Association of short alleles of a VNTR of the serotonin transporter gene with anxiety symptoms in patients presenting after deliberate self harm. Neuropharmacology 1997, 36:439-443.
20. Graeff F.G. Neurotransmitters in the dorsal periaqueductal grey and animal models of panic anxiety. New concepts in anxiety 1991, 288-312. MacMillan Press. M. Briley, S.E. File (Eds.).
21. Gray J.A. Drug effects on fear and frustration: possible limbic site of action of minor tranquilizers. Drugs, neurotransmitters and behaviour 1977, Vol. 8:433-529. Plenum Press, New York.
22. Gray J.A. The neuropsychology of anxiety: An enquiry in to the functions of the septo-hippocampal system 1982, Oxford University Press, Oxford.
23. Gray J.A. The psychology of fear and stress 1987, Cambridge University Press, London.
24. Gray J.A., McNaughton N. The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system 2000, Oxford University Press, Oxford.
25. Griebel G., Blanchard D.C., Blanchard R.J. Evidence that the behaviors in the mouse defense test battery relate to different emotional states: A factor analytic study. Physiology and Behavior 1996, 60:1255-1260.
26. Griebel G., Blanchard D.C., Jung A., Lee J.C., Masuda C.K., Blanchard R.J. Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: Effects of acute and chronic treatment with alprazolam. Neuropharmacology 1995, 34:1625-1633.
27. Haefely W. The GABAa-benzodiazepine receptor: Biology and pharmacology. Handbook of anxiety: The neurobiology of anxiety 1990, Vol. 3:165-187. Elsevier Science Publishers B.V.
28. Kapczinski F., Curran H., Gray J., Lader M. Flumazenil has an anxiolytic effect in simulated stress. Psychopharmacology 1994, 114:187-189.
29. Katsuragi S., Kunugi H., Sano A., Tsutsumi T., Isogawa K., Nanko S., et al. Association between serotonin transporter gene polymorphism and anxiety-related traits. Biological Psychiatry 1999, 45:368-370.
30. McNaughton N. Biology and emotion 1989, Cambridge University Press, Cambridge.
31. McNaughton N. Aminergic transmitter systems. Textbook of biological psychiatry 2002, 895-914. John Wiley & Sons. H. D'Haenen, J.A. Den Boer, H. Westenberg, P. Willner (Eds.).
32. McNaughton N., Corr P.J. A two-dimensional neuropsychology of defense: Fear/anxiety and defensive distance. Neuroscience and Biobehavioral Reviews 2004, 28:285-305.
33. McNaughton N., Corr P.J. Animal cognition and human personality. The reinforcement theory of personality 2008, 95-119. Cambridge University Press, Cambridge. P.J. Corr (Ed.).
34. Melke J., Landén M., Baghei F., Rosmond R., Holm G., Björntorp P., et al. Serotonin transporter gene polymorphisms are associated with anxiety-related personality traits in women. American Journal of Medical Genetics 2001, 105:458-463.
35. Noyes R., Burrows G.D., Reich J.H., Judd F.K., Garvey M.J., Norman T.R., et al. Diazepam versus alprazolam for the treatment of panic disorder. Journal of Clinical Psychiatry 1996, 57:349-355.
36. Ohara K., Nagai M., Suzuki Y., Ochiai M. Association between anxiety disorders and a functional polymorphism in the serotonin transporter gene. Psychiatry Research 1998, 81:277-279.
37. Paterson A., Whiting P.J., Gray J.A., Flint J., Dawson G.R. Lack of consistent behavioural effects of Maudsley reactive and non-reactive rats in a number of animal tests of anxiety and activity. Psychopharmacology 2001, 154:336-342.
38. Perkins A.M., Corr P.J. Reactions to threat and personality: Psychometric differentiation of intensity and direction dimensions of human defensive behaviour. Behavioural Brain Research 2006, 169:21-28.
39. Perkins A.M., Ettinger U., Davis R., Foster R., Williams S.C.R., Corr P.J. Effects of Lorazepam and Citalopram on human defensive reactions: Ethopharmacological differentiation of fear and anxiety. The Journal of Neuroscience 2009, 29:12617-12624.
40. Pittendrigh C.S. Adaptation, natural selection and behaviour. Behaviour and evolution 1958, Vol. 1. Yale University Press.
41. Redican W.K. An evolutionary perspective on human facial displays. Emotion in the human face 1982, Vol. 2. Cambridge University Press, Cambridge.
42. Rickels K., Rynn M. Pharmacotherapy of generalized anxiety disorder. Journal of Clinical Psychiatry 2002, 63:9-16.
43. Ricou B., Forster A., Bruckner A., Chastonay P., Gemperle M. Clinical evaluation of a specific benzodiazepine antagonist (Ro 15-1788): Studies in elderly patients after regional anaesthesia under benzodiazepine sedation. British Journal of Anaesthesia 1986, 58:1005-1011.
44. Sartory G., MacDonald R., Gray J.A. Effects of diazepam on approach, self-reported fear and psychophysiological responses in snake phobics. Behaviour Research and Therapy 1990, 28:273-282.
45. Stein D.J., Hollander E., Mullen L.S., DeCaria C.M., Liebowitz M.R. Comparison of clomipramine, alprazolam and placebo in the treatment of obsessive-compulsive disorder. Human Psychopharmacology 1992, 7:389-395.
46. Stein D.J., Vythilingum B., Seedat S. Pharmacotherapy of phobias. Evidence and experience in psychiatry 2004, Vol. 7. Phobias: John Wiley & Sons, Ltd.
47. Stevens J.C., Pollack M.H. Benzodiazepines in clinical practice. Consideration of their long-term use and alternative agents. Journal of Clinical Psychiatry 2005, 66:21-27.
48. Stouffer S.A., Lumsdaine A.A., Lumsdaine M.H., Williams R.M., Smith M.B., Janis I.L., et al. Studies in social psychology in World War II: Vol 2. The American soldier: Combat and its aftermath 1949, Princeton, cited by Broadhurst (1960, p. 37).
49. Sugarman J.M., Paul R.I. Flumazenil: A review. Pediatric Emergency Care 1994, 10:37-43.
50. Teicher M.H. Biology of anxiety. Medical Clinics of North America 1988, 72:791-814.
51. Viglinskaya I.V., Overstreet D.H., Kashevskaya O.P., Badishtov B.A., Kampov-Polevoy A.B., Seredenin S.B., et al. To drink or not to drink: Tests of anxiety and immobility in alcohol-preferring and alcohol-nonpreferring rat strains. Physiology and Behavior 1995, 57:987-991.
52. Wang Z., Valdes J., Noyes R., Zoega T., Crowe R.R. Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder. American Journal of Medical Genetics 1998, 81:228-234.
53. Westenberg H.G.M. Facing the challenge of social anxiety disorder. European Neuropsychopharmacology 1999, 9:S93-S99.
54. Wilson S., Glue P., Nutt D. Flumazenil and saccadic eye movements in patients with panic disorder and normal controls. Human Psychopharmacology: Clinical and Experimental 1992, 7:45-50.